Novel Coronavirus (COVID-19)

The U.S. Government announced on March 18, the release of $62 million from the Emergency Reserve Fund for Contagious Infectious-Disease Outbreaks (ERF) at the U.S. Agency for International Development (USAID) to address the pandemic of COVID-19, the disease caused by the novel coronavirus now called SARS-CoV-2. This funding fulfills the pledge of up to $100 million for international efforts to combat COVID-19 announced by the U.S. Department of State on February 7, 2020. USAID issued a determination to make these funds available from the ERF because the current pandemic is an emerging health threat with severe consequences to human health which is in the national interest of the United States to respond. Since cases of COVID-19 emerged in Wuhan City, in Hubei Province, in the People's Republic of China, the United States has continued to call on nations to comply with their obligations under the International Health Regulations (2005) and for other donors to contribute to the effort to address the disease.

USAID will use these new funds and the $37 million from the ERF previously authorized and announced for critical interventions in developing countries affected by, or at high-risk for, the COVID-19 pandemic. These activities will include heightened risk-communications and engagement with local communities; the prevention and control of infection in health facilities, including through the provision of personal protective equipment and other critical commodities; increasing laboratory, disease-surveillance, and rapid-response capacity; the management of cases of COVID-19; screening at points of entry; and global and regional coordination.

Individuals and groups who are interested in helping persons affected by, or at risk of, the disease caused by the novel coronavirus should visit the COVID-19 response page of the Center for International Disaster Information, at CIDI.org.

To learn more about COVID-19, please visit the response page from the Centers for Disease Control and Prevention within the U.S. Department of Health and Human Services.

Newly Announced Assistance

Of the total funding:

  • Funds that are going to the WHO will help the governments of currently affected or at-risk developing countries prepare their laboratories for large-scale testing for COVID-19, implement a public-health emergency plan for points of entry, activate case-finding and event-based surveillance for influenza-like illnesses, train and equip rapid-response teams, investigate cases and trace the contacts of infected persons, and adapt training materials for health workers on COVID-19.
  • Funds that are going through a broad range of other partners will support six broad areas of work: laboratory-strengthening; surveillance for, and rapid response to, infectious diseases; risk-communications and engagement with communities; public-health screening at points of entry; the prevention and control of infections in health facilities; and the management of cases of COVID-19. In addition, in response to the outbreak of COVID-19, which originated in Wuhan, in the People's Republic of China, USAID has reviewed, and responded to, requests from the governments of affected countries for donations from our emergency international stockpile of personal protective equipment (PPE). In close coordination with the WHO and the White House Coronavirus Task Force, this distribution of PPE - such as goggles, gowns, face shields/masks, and gloves- complements previous charitable donations from many U.S. private-sector entities.

Ongoing Assistance

For decades, the United States has been the world's largest provider of bilateral assistance in public health. Between USAID and the U.S. Department of State, American taxpayers generously have made available more than $90 billion dollars for health globally since 2009. This money has saved lives, protected people who are most vulnerable to disease, built health institutions, and promoted the stability of communities and nations. Of that figure, USAID has invested over $1.1 billion dollars since 2009 to prevent, detect, and respond to endemic and emerging health threats, including diseases like COVID-19. USAID's investments in global health security in the last 15 years, as well as contributions under the GHSA since 2015, have helped improve surveillance for deadly pathogens, strengthened laboratory systems, and refined risk-communications; funded the response to outbreaks of deadly illnesses; and addressed the rising threat of antimicrobial resistance. USAID designs our investments under the GHSA to protect the American public by helping to minimize the spread of disease in affected countries and improve local and global responses to outbreaks of infectious pathogens.

Individuals and groups who are interested in helping persons affected by, or at risk from, the novel coronavirus should visit the COVID-19 response page of the Center for International Disaster Information, at CIDI.org

WHAT WE'RE SAYING

What We're Saying About The Novel Coronavirus (COVID-19)

ADDITIONAL RESOURCES

FEMA.gov: Coronavirus Rumor Control
COVID-19 Guidance For Implementing Partners

 

Last updated: March 26, 2020

U.S., Mongolia Partner to Combat COVID-19 in Mongolia
March 24, 2020

The U.S. Embassy in Mongolia announced today that the U.S. Government has committed more than MNT3.3 billion ($1.2 million) to support the Government of Mongolia in its response to COVID-19 in the country. The U.S. Government, through the U.S. Agency for International Development (USAID), will collaborate with the Mongolian Ministry of Health (MOH), World Health Organization (WHO), and UNICEF to strengthen infection prevention and control.

The focus will be on infection control, disease prevention, detection, diagnosis, treatment, and public information.
March 20, 2020

The U.S. government, through the United States Agency for International Development (USAID), is granting more than 66 million soms ($913,000) to three specialized organizations to increase the Kyrgyz Republic’s ability to respond to the ongoing COVID-19  pandemic. The focus will be on infection control, disease prevention, detection, diagnosis, treatment, and public information. These priority areas and interventions were designed in consultations with the Ministry of Health and the Government of the Kyrgyz Republic.

March 20, 2020

The United States Government announced nearly $2 million in funding from the U.S. Agency for International Development (USAID) to expand U.S. support for Thailand in response to the global spread of COVID-19.  This support builds upon ongoing USAID and other U.S. Government investments in health development, particularly those aimed at building the capacity to prevent, detect and respond to infectious diseases. Specifically, $700,000 will be implemented through the World Health Organization (WHO), $329,000 through the United Nations Children’s Fund (UNICEF), and $800,000 through the Infectious Disease Detection and Surveillance (IDDS) project, which collectively contribute to the U.S. Government’s Global Health Security Strategy. 

March 18, 2020

The U.S. Government announced today the release of $62 million from the Emergency Reserve Fund for Contagious Infectious-Disease Outbreaks (ERF) at the U.S. Agency for International Development (USAID) to address the pandemic of COVID-19, the disease caused by the novel coronavirus now called SARS-CoV-2.

U.S., DOH Partner to Combat COVID-19 in the Philippines
March 17, 2020

The U.S. Embassy in the Philippines announced today that the U.S. government has committed more than Php139 million ($2.7 million) to support the Philippine Department of Health (DOH) in its response to COVID-19 in the country.

Pages